Carolina Pereira

Ms. Carolina Pereira

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in European Journal of Pharmaceutics and Biopharmaceutics
Verified
Journal Article
Closed access
Marco CavacoMarco Cavaco
Marco Cavaco
CPCarolina Pereira
Carolina Pereira
BKBruna Kreutzer
Bruna Kreutzer
Luis Pleno GouveiaLuis Pleno Gouveia
Luis Pleno Gouveia
BSBeatriz Silva-Lima
Beatriz Silva-Lima
MVMafalda Videira
Mafalda Videira

1 March 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
AAAlexandra Arranja
Alexandra Arranja
Luis Pleno GouveiaLuis Pleno Gouveia
Luis Pleno Gouveia
PGPetra Gener
Petra Gener
Diana RafaelDiana Rafael
Diana Rafael
CPCarolina Pereira
Carolina Pereira
MVMafalda A. Videira
Mafalda A. Videira

1 October 2020 in Open Biology
Verified
Journal Article
Open access
IMInês Milagre
Inês Milagre
CPCarolina Pereira
Carolina Pereira
RORaquel A. Oliveira
Raquel A. Oliveira
LJLars E. T. Jansen
Lars E. T. Jansen
Pluripotent stem cells (PSCs) are central to development as they are the precursors of all cell types in the embryo. Therefore, maintaining a stable karyotype is essential, both for their physiological role as well as for their use in regenerative medicine. Karyotype abnormalities in PSCs in culture are common but the underlying causes remain unknown. To gain insight, we explore the composition of the centromere and kinetochore in human embryonic and induced PSCs. Centromere function depends on CENP-A nucleosome-defined chromatin. We show that while PSCs maintain abundant pools of CENP-A, CENP-C and CENP-T, these essential centromere components are strongly reduced at stem cell centromeres. Outer kinetochore recruitment is also impaired to a lesser extent, indicating an overall weaker kinetochore while the inner centromere protein Aurora B remains unaffected. We further show that, similar to differentiated human cells, CENP-A chromatin assembly in PSCs requires transition into G1 phase. Finally, reprogramming experiments indicate that reduction of centromeric CENP-A levels is an early event during dedifferentiation, coinciding with global chromatin remodelling. Our characterization of centromeres in human stem cells suggests a possible link between impaired centromere function and stem cell aneuploidies.

9 January 2015 in Current Cancer Drug Targets
Verified
Journal Article
Closed access
PDF file
SHSara Horta
Sara Horta
AAAna L. Agostinho
Ana L. Agostinho
RMRita Mateus
Rita Mateus
LPLucilia Pereira
Lucilia Pereira
CPCarolina Pereira
Carolina Pereira
MVMafalda Videira
Mafalda Videira
The expression of CD44 tags cells with stemness-associated properties (cancer initiating cells or cancer stem cells - CSC). This membrane glycoprotein with a cytoplasmic domain indirectly associated with the cellular cytoskeleton, has a crucial role in tumorigenesis. The CD44 receptor enables the cell to respond to changes in tumor microenvironment, promoting several signaling events related to tumor initiation, progression and fixation in distant host tissues. Although the contribution of this transmembrane protein in gene regulation remains unclear, its overexpression in adenocarcinomas, mostly supported by microRNA (miR)-mediated upregulation of target mRNA, is widely accepted. Herein, we gather the evidence that CD44 is one of the most predominant markers of malignant cells and may be found in diverse phenotypes associated with tumor progression. Additionally, CD44 tumor receptors were found to have different roles at a transcriptional level. Thus, innovative therapeutic strategies should rely heavily on its metastasis-promoting ability. Furthermore, the concept of selectively targeting cell sub-populations may be used to develop specific therapeutic and/or diagnostic systems. An approach based on targeting CD44+ cells might provide a strategy to design guided-therapeutic systems against multiple malignant cells including putative CSC.

Verified
Journal Article
Open access
PDF file
IMInes Milagre
Ines Milagre
CPCarolina Pereira
Carolina Pereira
RORaquel A Oliveira
Raquel A Oliveira
Human pluripotent stem cells (PSCs), which include both embryonic and induced pluripotent stem cells, are widely used in fundamental and applied biomedical research. They have been instrumental for better understanding development and cell differentiation processes, disease origin and progression and can aid in the discovery of new drugs. PSCs also hold great potential in regenerative medicine to treat or diminish the effects of certain debilitating diseases, such as degenerative disorders. However, some concerns have recently been raised over their safety for use in regenerative medicine. One of the major concerns is the fact that PSCs are prone to errors in passing the correct number of chromosomes to daughter cells, resulting in aneuploid cells. Aneuploidy, characterised by an imbalance in chromosome number, elicits the upregulation of different stress pathways that are deleterious to cell homeostasis, impair proper embryo development and potentiate cancer development. In this review, we will summarize known molecular mechanisms recently revealed to impair mitotic fidelity in human PSCs and the consequences of the decreased mitotic fidelity of these cells. We will finish with speculative views on how the physiological characteristics of PSCs can affect the mitotic machinery and how their suboptimal mitotic fidelity may be circumvented.

29 June 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
IMInes Milagre
Ines Milagre
CPCarolina Pereira
Carolina Pereira
RORaquel A Oliveira
Raquel A Oliveira
Human pluripotent stem cells (PSCs), which include both embryonic and induced pluripotent stem cells, are widely used in fundamental and applied biomedical research. They have been instrumental for better understanding development and cell differentiation processes, disease origin and progression, and can aid in the discovery of new drugs. PSCs also hold great potential in regenerative medicine to treat or diminish the effects of certain debilitating diseases, such as degenerative disorders. However, some concerns have recently been raised over their safety for the use in regenerative medicine. One of the major concerns is the fact that PSCs are prone to errors in passing the correct number of chromosomes to daughter cells, resulting in aneuploid cells. Aneuploidy, characterised by an imbalance in chromosome number, elicits the upregulation of different stress pathways that are deleterious to cell homeostasis, impair proper embryo development and can potentiate cancer development. In this review we will summarise known molecular mechanisms recently revealed to impair mitotic fidelity in human PSCs and the consequences of the decreased mitotic fidelity of these cells. We will finish with speculative views on how the physiological characteristics of PSCs can affect the mitotic machinery and how their suboptimal mitotic fidelity may be circumvented.